CSPG4
Chondroitin sulfate proteoglycan 4 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||
Symbols | CSPG4 ; MSK16; HMW-MAA; MCSP; MCSPG; MEL-CSPG; NG2 | ||||||||||
External IDs | Template:OMIM5 Template:MGI HomoloGene: 20445 | ||||||||||
| |||||||||||
RNA expression pattern | |||||||||||
More reference expression data | |||||||||||
Orthologs | |||||||||||
Template:GNF Ortholog box | |||||||||||
Species | Human | Mouse | |||||||||
Entrez | n/a | n/a | |||||||||
Ensembl | n/a | n/a | |||||||||
UniProt | n/a | n/a | |||||||||
RefSeq (mRNA) | n/a | n/a | |||||||||
RefSeq (protein) | n/a | n/a | |||||||||
Location (UCSC) | n/a | n/a | |||||||||
PubMed search | n/a | n/a |
Chondroitin sulfate proteoglycan 4, also known as CSPG4, is a human gene.[1]
A human melanoma-associated chondroitin sulfate proteoglycan plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. CSPG4 represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells.[1]
References
Further reading
- Pluschke G, Vanek M, Evans A; et al. (1996). "Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan". Proc. Natl. Acad. Sci. U.S.A. 93 (18): 9710–5. PMID 8790396.
- Kirschfink M, Blase L, Engelmann S, Schwartz-Albiez R (1997). "Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1". J. Immunol. 158 (3): 1324–31. PMID 9013976.
- Iida J, Meijne AM, Oegema TR; et al. (1998). "A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion". J. Biol. Chem. 273 (10): 5955–62. PMID 9488735.
- Eisenmann KM, McCarthy JB, Simpson MA; et al. (2000). "Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas". Nat. Cell Biol. 1 (8): 507–13. doi:10.1038/70302. PMID 10587647.
- Barritt DS, Pearn MT, Zisch AH; et al. (2000). "The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2". J. Cell. Biochem. 79 (2): 213–24. PMID 10967549.
- Iida J, Pei D, Kang T; et al. (2001). "Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen". J. Biol. Chem. 276 (22): 18786–94. doi:10.1074/jbc.M010053200. PMID 11278606.
- Staub E, Hinzmann B, Rosenthal A (2002). "A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defines a new protein family". FEBS Lett. 527 (1–3): 114–8. PMID 12220645.
- Stegmüller J, Werner H, Nave KA, Trotter J (2003). "The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling". J. Biol. Chem. 278 (6): 3590–8. doi:10.1074/jbc.M210010200. PMID 12458226.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Legg J, Jensen UB, Broad S; et al. (2004). "Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis". Development. 130 (24): 6049–63. doi:10.1242/dev.00837. PMID 14573520.
- Ghali L, Wong ST, Tidman N; et al. (2004). "Epidermal and hair follicle progenitor cells express melanoma-associated chondroitin sulfate proteoglycan core protein". J. Invest. Dermatol. 122 (2): 433–42. doi:10.1046/j.0022-202X.2004.22207.x. PMID 15009727.
- Fukushi J, Makagiansar IT, Stallcup WB (2005). "NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin". Mol. Biol. Cell. 15 (8): 3580–90. doi:10.1091/mbc.E04-03-0236. PMID 15181153.
- Yang J, Price MA, Neudauer CL; et al. (2004). "Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms". J. Cell Biol. 165 (6): 881–91. doi:10.1083/jcb.200403174. PMID 15210734.
- Colland F, Jacq X, Trouplin V; et al. (2004). "Functional proteomics mapping of a human signaling pathway". Genome Res. 14 (7): 1324–32. doi:10.1101/gr.2334104. PMID 15231748.
- Suzuki Y, Yamashita R, Shirota M; et al. (2004). "Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions". Genome Res. 14 (9): 1711–8. doi:10.1101/gr.2435604. PMID 15342556.
- Makagiansar IT, Williams S, Dahlin-Huppe K; et al. (2005). "Phosphorylation of NG2 proteoglycan by protein kinase C-alpha regulates polarized membrane distribution and cell motility". J. Biol. Chem. 279 (53): 55262–70. doi:10.1074/jbc.M411045200. PMID 15504744.
- Petrini S, Tessa A, Stallcup WB; et al. (2006). "Altered expression of the MCSP/NG2 chondroitin sulfate proteoglycan in collagen VI deficiency". Mol. Cell. Neurosci. 30 (3): 408–17. doi:10.1016/j.mcn.2005.08.005. PMID 16169245.
- Brekke C, Lundervold A, Enger PØ; et al. (2006). "NG2 expression regulates vascular morphology and function in human brain tumours". Neuroimage. 29 (3): 965–76. doi:10.1016/j.neuroimage.2005.08.026. PMID 16253523.
- Liu T, Qian WJ, Gritsenko MA; et al. (2006). "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry". J. Proteome Res. 4 (6): 2070–80. doi:10.1021/pr0502065. PMID 16335952.
- Luo W, Wang X, Kageshita T; et al. (2006). "Regulation of high molecular weight-melanoma associated antigen (HMW-MAA) gene expression by promoter DNA methylation in human melanoma cells". Oncogene. 25 (20): 2873–84. doi:10.1038/sj.onc.1209319. PMID 16407841.
This protein-related article is a stub. You can help Wikipedia by expanding it. |